BioSig Technologies, Inc. (STEX)
NASDAQ · Financial Services
BioSig Technologies, Inc. Operating Income 2020–2024
BioSig Technologies, Inc. annual/quarterly operating income history and growth rate from 2020 to 2024. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- BioSig Technologies, Inc. operating income for the quarter ending June 30, 2024 was -5.3 M, a 51.49% decrease year-over-year.
- BioSig Technologies, Inc. operating income for the twelve months ending June 30, 2024 was -23.7 M, a 14.34% decrease year-over-year.
- BioSig Technologies, Inc. annual operating income for 2024 was -12.9 M, a 54.89% decrease from 2023.
- BioSig Technologies, Inc. annual operating income for 2023 was -28.5 M, a 4.57% increase from 2022.
- BioSig Technologies, Inc. annual operating income for 2022 was -27.3 M, a 18.40% decrease from 2021.
- BioSig Technologies, Inc. annual operating income for 2021 was -33.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioSig Technologies, Inc. Operating Income — FAQ
BioSig Technologies, Inc. (STEX) operating income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is BioSig Technologies, Inc.'s operating income?
BioSig Technologies, Inc. (STEX) reported operating income of -$13M for fiscal 2024.
Where can I see STEX's operating income history?
The chart and table above show BioSig Technologies, Inc.'s operating income by year and by quarter, including the growth rate.